Insider Trading: Avanir Pharmaceuticals Inc (AVNR.O)

AVNR.O on Nasdaq

3.41USD
24 May 2013
Price Change (% chg)

$0.01 (+0.29%)
Prev Close
$3.40
Open
$3.38
Day's High
$3.43
Day's Low
$3.32
Volume
1,105,857
Avg. Vol
1,219,852
52-wk High
$4.05
52-wk Low
$2.07

Search Stocks
KATKIN KEITH A Options Exercised: 0
Trade Date: Tuesday, 15 Nov 2011 Price: 2.59
Title: Chief Executive Officer Shares Held: 208,352
Type Traded: Direct Net Change in Shares This Filing: 0
» More Insider Trading

Institutional Holders

% Shares Owned: 69.59%
# of Holders: 113
Total Shares Held: 100,975,137
3 Mo. Net Change: 4,162,474
# New Positions: 10
# Closed Positions: 14
# Increased Positions: 53
# Reduced Positions: 41
# Net Buyers: 12

Officers & Directors

Name Age Since Current Position

Craig Wheeler

 52 2007 Independent Chairman of the Board

Keith Katkin

 41 2007 President, Chief Executive Officer, Director

Christine Ocampo

 40 2010 Principal Financial Officer, Vice President - Finance

Joao Siffert

 48 2011 Senior Vice President - Research and Development, Chief Scientific Officer

Gregory Flesher

 42 2011 Senior Vice President - Corporate Development, Chief Business Officer

Randall Kaye

 50 2007 Senior Vice President - Medical Affairs, Chief Medical Officer

Rohan Palekar

 47 2012 Senior Vice President, Chief Commercial Officer

Corinne Nevinny

 53 2013 Director

Hans Bishop

 48 2012 Independent Director

David Mazzo

 55 2005 Independent Director

Dennis Podlesak

 2005 Independent Director

Scott Whitcup

 53 2005 Independent Director

Ian Clements

 IR Contact Officer
Search Stocks